In order to clarify this question, we sought to conduct a systematic review and meta-analysis to estimate the prognostic importance of p16 methylation status for overall survival (OS) and disease-free survival (DFS) in patients with NSCLC. Here, CDKN2A is linked to non-small cell lung carcinoma.